Medical debt?
Learn about the Medical Debt Case Management Program
Cancer care shouldn’t be a financial burden. We’re helping patients find options to address their medical debt.
The Co-pay Assistance Program [[toc="Overview"]]
Provideing assistance toward the cost of Private, Medicare, Medicaid, and TRICARE insurance premiums, and treatment-related co-pays and co-insurance for prescription drugs, labs, scans, tests, etc.
Award levels vary by disease fund.
Available funding
Funding for the Co-pay program is provided by pharmaceutical and biotech companies and is not supported by other sources of revenue including our fundraising campaigns such as Team In Training, Light The Night, Student Series, Leukemia Cup Regatta, Man & Woman of the Year, or Student of the Year. These campaigns support Blood Cancer United patient education, support services, advocacy, and research.
A fund that is “closed” is at maximum capacity, serving those enrolled, and is not enrolling additional patients (new or renewal patients). We do not keep a waitlist and encourage all to continue to check the website for updates.
Please note: Changes to funds are reflected on this webpage as quickly as possible. For up-to-the-minute fund status, please call (877) 557-2672. If you started an application prior to a fund becoming fully subscribed, please continue with the application.
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Acute promyelocytic leukemia (APL)
- BPDCN
- Erdheim Chester Disease
- Mast cell leukemia
- Mastocytosis
- Chronic lymphocytic leukemia (CLL or SLL)
- B cell prolymphocytic leukemia (B PLL)
- Hairy cell leukemia (HCL)
- Large granular lymphocytic leukemia (LGL)
- Richter's transformation of CLL
- Chronic myeloid leukemia (CML)
- Patients with blood cancer enrolled in a blood cancer clinical trial
- Hodgkin lymphoma (HL)
- All Non Hodgkin lymphomas (NHL)
- Lymphomatoid papulosis
- Post transplant lymphoproliferative disorder or PTLD
- Mantle cell lymphoma (MCL)
- Myelodysplastic syndromes (MDS)
- Chronic myelomonocytic leukemia (CMML)
- Juvenile myelomonocytic leukemia (JMML), diagnosis formerly known as chronic myelomonocytic leukemia of infancy [CMML]
- MDS/MDP overlap syndrome
- Myeloma or multiple myeloma (MM)
- Plasma cell leukemia or plasma cell myeloma
- POEMS syndrome
- MGUS
- Myelofibrosis (MF)
- Essential thrombocythemia (ET)
- Polycythemia Vera (PV)
- Chronic Neutrophilic Leukemia (CNL)
- Chronic Eosinophilic Leukemia (CEL)
Philadelphia chromosome negative myeloproliferative neoplasms only.
- Waldenstrom macroglobulinemia (WM)
*The Chronic Myeloid Leukemia (CML) Co-pay fund is fully subscribed but not permanently closed.
Funding for the Co-pay program is provided by pharmaceutical and biotech companies and is not supported by other sources of revenue including our fundraising campaigns such as Team In Training, Light The Night, Student Series, Leukemia Cup Regatta, Man & Woman of the Year, or Student of the Year. These campaigns support Blood Cancer United patient education, support services, advocacy, and research.
*Based upon historical and recent trends, we anticipate that the CLL Co-pay fund will be open through the winter of 2025.
The Inflation Reduction Act highlights changes in Medicare for 2024 and 2025:
-
For Medicare plan year 2024 patients will see a new limit
on their cost-sharing for their Part D drugs
- If a patient is taking exclusively brand drugs: they will reach the out-of-pocket cap at around $3,300.
- If a patient is taking exclusively generic drugs: they will reach the out-of-pocket cap at $8,000.
- Starting in 2025 there will be a new $2,000 annual cap on Medicare patients’ out-of-pocket prescription drug costs
Additional resource links:
https://www.cms.gov/inflation-reduction-act-and-medicare
https://www.cms.gov/files/document/10522-inflation-reduction-act-timeline.pdf
We can help pay for:
- Medical insurance premiums
- Treatment-related co-pays, deductibles, and co-insurance (for expenses covered by the program)
- Co-pays for prescription medication related to prescribed treatment
- Co-pays for non-diagnostic labs, scans, and tests.
Blood Cancer United can pay your provider directly or reimburse you for payments already made. You have complete freedom to choose doctors, providers, suppliers, insurance companies and treatment-related medications. You can make changes to these at any time without affecting your continued eligibility.
*Updated* See a list of covered and non-covered expenses (PDF).
To be eligible for Co-pay assistance, you must
- Be a United States citizen or permanent resident and reside in the U.S. or a U.S. territory.
- Members of the U.S. military, diplomats, etc. who may be serving overseas, must have a U.S. address and use it on the application.
- Have a household income that is at or below 600 percent of the U.S. federal poverty guidelines (PDF) as adjusted by the Cost of Living Index (COLI). You will be asked for your zip code to determine your COLI.
- Have medical insurance
- Have a blood cancer diagnosis confirmed by a doctor
- The patient must be in active treatment, scheduled to begin treatment, or is being monitored by their doctor.
- For members of the U.S. military, diplomats, etc. who may be serving overseas, the healthcare provider attesting to the diagnosis must have a National Provider Identification (NPI) number and use it on the application.
Blood Cancer United offers patients, caregivers, pharmacies, and healthcare providers two easy ways to apply on behalf of a patient:
What you need to apply (PDF)
By phone: (877) 557-2672 (Hablamos español)
Speak with an Intake Specialist, Monday to Friday, 8:30 a.m. to 5:00 p.m., who can walk you through the application process
Online portal
24/7, available in English only
If this is your first time visiting the Blood Cancer United Financial Assistance Online Portal, you will need to register before you can apply.
Online Portal Registration Guide (PDF)
Need help?
For portal technical support, please call us at (877) 557-2672 or
e-mail [email protected].
Approved patients must submit a claim for a covered expense every 90 days to keep their accounts active.
How to submit a claim (PDF)
See our claim videos to view our claim videos that provide step-by-step instructions on how to submit a claim
You may also contact the Co-pay Assistance Program at (877) 557-2672 for instructions on how to submit a claim.
- Program FAQs
- Claim FAQs
- Patient Financial Assistance Programs At A Glance: Provides an overview of program eligibility, assistance details, and award cycles
As a charity, Blood Cancer United is exempt from federal income tax and individuals who receive assistance from a charity to meet their personal needs do not generally have to pay federal income tax on the value of the assistance they receive. With this being said it should not affect their ability to receive financial assistance from the government or affect their income taxes.
Blood Cancer United
Co-pay Assistance Program
P.O. Box 12268
Newport News, VA 23612
Email: [email protected]
Toll Free Phone: (877) 557-2672
Fax: (877) 267-2932
- Co-Pay Compliance 1-Pager (PDF)
- 7 Elements of an Effective Compliance Program (PDF)
- OIG Advisory Opinion No. 06-13 (PDF) dated 9.18.06
- OIG Advisory Opinion No. 06-13 (PDF) dated 6.21.13
- Other Financial Assistance
- Financial Resources (Other Helpful Organizations)
- Access the Co-Pay Resource Guide (PDF) for information regarding Pharmaceutical Patient Assistance Programs.
Understand Insurance Basics
Blood Cancer United resources
Find free, specialized guidance and information for every type of blood cancer, request financial support, find emotional support, and connect with other members of the blood cancer community.
